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Abstract
In addition to hepatocytes, the liver comprises a host of specialised non-parenchymal cells which are important to consider 
in the development of in vitro models which are both physiologically and toxicologically relevant. We have characterized 
a 3D co-culture system comprising primary human hepatocytes (PHH) and non-parenchymal cells (NPC) and applied it to 
the investigation of acetaminophen-induced toxicity. Firstly, we titrated ratios of PHH:NPC and confirmed the presence of 
functional NPCs via both immunohistochemistry and activation with both LPS and TGF-β. Based on these data we selected 
a ratio of 2:1 PHH:NPC for further studies. We observed that spheroids supplemented with NPCs were protected against 
acetaminophen (APAP) toxicity as determined by ATP (up to threefold difference in  EC50 at day 14 compared to hepatocytes 
alone) and glutathione depletion, as well as miR-122 release. APAP metabolism was also altered in the presence of NPCs, 
with significantly lower levels of APAP-GSH detected. Expression of several CYP450 enzymes involved in the bioactivation 
of APAP was also lower in NPC-containing spheroids. Spheroids containing NPCs also expressed higher levels of miRNAs 
which have been implicated in APAP-induced hepatotoxicity, including miR-382 and miR-155 which have potential roles in 
liver regeneration and inflammation, respectively. These data indicate that the interaction between hepatocytes and NPCs can 
have significant metabolic and toxicological consequences important for the correct elucidation of hepatic safety mechanisms.
Keywords Hepatotoxicity · 3D models · miRNA · In vitro toxicology
Introduction
The liver is a key organ in the detoxification of chemicals 
and drugs, performing a multitude of metabolic reactions 
which ultimately result in clearance and excretion. It is also a 
frequent site of drug-induced toxicity reactions, with hepato-
toxicity a leading cause of post-marketing drug withdrawals 
(Onakpoya et al. 2016). This is, in part, due to its exposure 
to chemically reactive metabolites formed as a result of bio-
activation (Park et al. 2011). Predicting the potential of a 
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new medicine to cause drug-induced liver injury (DILI) in 
man is, however, complicated by species differences in both 
the expression and activity of a number of proteins involved 
in the absorption, distribution, metabolism, and excretion 
(ADME) of drugs (Martignoni et al. 2006). In vitro systems 
which incorporate well-characterised human cells and/or 
tissue are therefore becoming increasingly important in the 
development of safe medicines (Baker et al. 2018; Godoy 
et al. 2013; Weaver and Valentin 2019).
Though hepatocytes are the predominant cell of the liver, 
comprising approximately 80% of its total mass, a number of 
other, specialised cells with key functions are also present. 
These include Kupffer cells, hepatic resident macrophages, 
stellate cells which produce collagen and store vitamin A, 
and liver sinusoidal endothelial cells (LSECs), which pro-
vide a permeable barrier between the blood and the space of 
Disse. In addition to their individual functions, the commu-
nication between these cells through the release of soluble 
factors such as cytokines and chemokines is key to liver 
homeostasis, including the response to invading pathogens, 
or toxic insult (Robinson et al. 2016). In the case of DILI, 
non-parenchymal cells may be directly targeted or activated 
in response to the release of damage-associated molecular 
patterns (DAMPs), such as intracellular proteins or nucleo-
tides from damaged hepatocytes (Godoy et al. 2013).
Despite a drive for more patient-relevant assays to be 
included at an earlier stage in drug development, model-
ling hepatotoxicity in vitro can be a difficult task. Although 
researchers have access to primary human cells, the loss of 
phenotype that occurs upon plating in 2D is a huge barrier in 
the investigation of DILI, particularly where metabolic acti-
vation is required (Heslop et al. 2016; Lauschke et al. 2016a, 
b; Rowe et al. 2010). Three-dimensional hepatocyte sphe-
roids have recently emerged as a promising in vitro model 
in which the phenotype of primary cells can be maintained 
for several weeks (Bell et al. 2016). Although the possibil-
ity of including additional non-parenchymal cells (NPCs) 
such as Kupffer cells (Messner et al. 2013) stellate cells and 
liver sinusoidal endothelial cells (Bell et al. 2016; Proctor 
et al. 2017) has been investigated, little has been reported 
surrounding their role in drug toxicity. Furthermore, little is 
known about the behaviour of NPCs when cultured in more 
advanced in vitro models both in terms of their phenotype 
and function.
In addition to considering the cell types included in 
hepatic model systems, the choice of relevant endpoints 
which are applicable to human toxicity is also extremely 
important. Measuring biomarkers of liver injury which can 
also be monitored in patient populations increases the trans-
latability of any in vitro assay. In particular, miRNAs are of 
significant interest due to their relative stability in biological 
fluids, frequent tissue specificity and conservation between 
different species. Indeed, miR-122 represents one of the few 
biomarker candidates that can be monitored across preclini-
cal animal models, in vitro cell assays and in the clinic (Kia 
et al. 2015a, b; Lewis et al. 2011; Wang et al. 2009). It is 
highly liver-specific and may be more sensitive than tradi-
tional protein biomarkers in identifying patients at risk of 
developing severe liver injury (Antoine et al. 2013).
In the current study, we have generated a co-culture 
model containing both primary human hepatocytes (PHH) 
and NPC, and used this model to investigate how NPCs 




Maintenance media comprised Williams E media sup-
plemented with 2  mM L-glutamine, 100  U/ml penicil-
lin, 100  μg/ml streptomycin, 10  μg/ml insulin, 5.5  μg/
ml transferrin, 6.7  ng/ml sodium selenite and 100  nM 
dexamethasone.
Generation of mono‑ and co‑culture spheroids
Cryopreserved primary cells from a single hepatocyte 
donor and four NPC donors were purchased from BioIVT 
and Lonza, respectively. Characteristics of these donors are 
reported in Table 1.
Cryopreserved hepatocytes were thawed according to the 
suppliers’ instructions, resuspended in maintenance medium 
supplemented with 10% foetal bovine serum (FBS; Gibco) 
and counted. 1500 cells/well were then seeded in ultra-low 
attachment plates (Corning) and centrifuged for 2 min at 
125 × g. For co-culture spheroids, mixed NPCs were added 
to the cell suspension at various ratios prior to centrifu-
gation. All spheroids contained 1500 hepatocytes. After 
4–5 days a 50% media change was performed with FBS-free 
media and this was repeated daily until day 8 after seeding, 
when treatments began and which will now be referred to 
as day 0.
Table 1  Characteristics of cryopreserved hepatocyte and non-paren-
chymal cell donors
PHH primary human hepatocyte, NPC non-parenchymal cell
Cells Sex Age Race Cause of death
PHH1 Female 78 Caucasian Stroke
NPC1 Female 43 Hispanic Unknown
NPC2 Male 12 Caucasian Unknown
NPC3 Female 55 Caucasian Unknown
NPC4 Female 19 months African American Unknown
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NPC activation with LPS and/or TGF‑β
At day 0, day 7, or day 14 spheroids were challenged with 
lipopolysaccharide (LPS; 10 μg/ml; Sigma) for 48 h, after 
which media was collected and stored at −80 ℃ until analy-
sis. The amount of secreted IL-6 was then quantified via 
high sensitivity ELISA (Invitrogen), according to the man-
ufacturer’s instructions. To assess stellate cell activation, 
spheroids were challenged with 10 ng/ml TGF-β (Sigma) at 
day 0 and collected for immunohistochemistry and mRNA 
analysis after 72 h.
APAP treatment and viability and glutathione 
measurements
Acetaminophen (0–10 mM) was diluted in maintenance 
media and a full media change with the compound was 
performed every 2–3 days. At each timepoint cellular ATP 
content was determined using the Cell-TiterGlo reagents 
(Promega). Media was removed and 25 µl of the reagent 
was added. After a 20 min incubation at 37 ℃, luminescence 
was measured. Total glutathione was determined using the 
GSH-glo kit (Promega) according to the manufacturers 
instructions. All measurements were obtained from indi-
vidual spheroids. Dose–response curves were generated in 
GraphPad Prism 8.0.1.
miRNA and mRNA analysis
Total RNA was isolated from spheroids or media samples 
(50 µl) using the miRNeasy kit from Qiagen.
For mRNA analysis, approximately 20 spheroids were 
pooled and 75 ng RNA was reverse transcribed using the 
High Capacity cDNA reverse transcription kit (Applied 
Biosystems). TaqMan primers and probes for each gene 
of interest were purchased from Applied Biosystems. Data 
were analysed using the ΔΔCt method against the reference 
gene GAPDH.
For miRNA analysis, six spheroids were collected. 
cDNA was prepared from 2  µl total RNA using the 
TaqMan Advanced miRNA cDNA synthesis kit (Applied 
Biosystems) and expression of a panel of miRNAs was 
assessed by qPCR using TaqMan miRNA advanced 
probes. Relative expression of each miRNA was nor-
malised to the endogenous U6 snRNA using the ΔΔCt 
method. For media samples, a standard curve was gener-
ated using synthetic miR-122 and unknown samples were 
interpolated accordingly.
APAP metabolism
50 µl media from APAP-treated spheroids was collected 
and quenched with 150 µl acetonitrile containing 15 nM 
of the internal standard (IS) 5,5-diethyl-1,3-diphenyl-
2-iminobarbituric acid and 0.8% formic acid. Samples 
were centrifuged (2100 × g, 20 min, 4 °C) and 50 µl of 
the resulting supernatant was diluted 1:3 with  ddH2O and 
further dilutions were performed with acetonitrile:ddH2O 
(19:81 v/v) containing 0.15% formic acid and 2.8 nM IS. 
Quantification was achieved on a triple-quadrupole mass 
spectrometer (XevoTQ-S; Waters, Milford, MA, USA) 
equipped with an Acquity ultraperformance liquid chro-
matography (UPLC) I-Class system (Waters Corporation, 
MA, USA). The MS system was equipped with an elec-
trospray ionisation source and settings were as follows: 
capillary voltage 0.5 kV; desolvation temperature 600 °C; 
cone gas flow 150 l/h; nebulizer gas 7.0 bar; collision gas 
flow 0.15 ml/min. MSMS optimization was performed for 
all the metabolites and conditions are specified in Table 2. 
Separation was performed using a Waters Acquity  UPLC® 
HSS T3 column (50 mm × 2.1 mm, 1.8 μm) fitted with a 
column heater set to 40 °C. The mobile phase consisted 
of solvent A (0.1% formic acid in dd-H2O) and solvent B 
(0.1% formic acid in acetonitrile). The elution profile was: 
0.2% B, 0.00 to 0.30 min; linear gradient to 15% B, 0.31 
to 1.80 min; isocratic hold, 1.81 to 2.40 min; 5% B, 2.41 
to 2.46 min; re-equilibration to 0.2% B 2.47 to 3 min. The 
flow rate was 1.0 ml/min. The injection volume was 2 μl.
Immunohistochemistry
Spheroids were collected and pooled, washed in PBS, and 
fixed in formalin for 1 h at room temperature. After washing 
Table 2  MS parameters for 
determination of APAP and 
metabolites
Metabolite MRM (parent →  
daughter) m/z




APAP 152.01 → 109.96 0.014 40 16
APAP-glucuronide 328.2 → 152.15 0.014 15 20
APAP-sulfate 229.93 → 149.89 0.014 10 22
APAP-GSH 457.16 → 139.97 0.014 50 40
5,5-Diethyl-1,3-diphenyl-2-imin-
obarbituric acid (IS)
336.21 → 195.00 0.014 40 16
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twice in PBS, spheroids were transferred to a cryomold and 
suspended in Histogel, before paraffin embedding and sec-
tioning (4 μm). Cellular morphology was assessed via hema-
toxylin and eosin (H+E) staining, and immunohistochem-
istry was performed using the Ventana Ultra and associated 
reagents from Roche. Details of the conditions for each of 
the antibodies used are reported in Table 3.
Results
Characterisation of NPC‑containing spheroids
To determine the optimal number of NPCs for co-culture 
with primary human hepatocytes, the ratio of PHH:NPC 
was titrated. All spheroids contained 1500 hepatocytes, 
but NPCs were added at the indicated ratios. Addition 
of supplementary NPCs did not have any detrimental 
effect on spheroid viability, with equivalent ATP lev-
els measured in all conditions (Fig. 1a). The presence 
of functional Kupffer cells was confirmed through the 
measurement of secreted IL-6 following LPS challenge. 
Although hepatocyte only spheroids also responded to 
LPS treatment, increased IL-6 was detected with the 
addition of increasing numbers of NPCs (Fig. 1b). After 
14 days in culture only the spheroids with the greatest 
number of NPCs (2:1) were still responsive to LPS chal-
lenge, likely due to either a loss of the cells from the 
spheroid or a loss of functionality. Based on these data 
the 2:1 ratio was selected for further experiments. Cel-
lular morphology was assessed via H+E staining and 
established that viable cells were present at the core of 
the spheroid (Fig. 1b). The presence of Kupffer cells 
(CD68 +) was confirmed using immunohistochemistry, 
which showed an even distribution of the NPCs through-
out the spheroid (Fig. 1b). Stellate cells exist in multiple 
activation states which can be difficult to track, particu-
larly when they are cultured in vitro. Here, we observed 
faint α-SMA staining, a classical marker of activated 
stellate cells, in untreated spheroids supplemented with 
NPCs. To understand whether this represented true acti-
vation of the stellate cells, spheroids were treated with 
TGF-β, whereupon a significant increase in α-SMA and 
COL1A1 was observed at both the protein and RNA level 
(Fig. 1c, d). This suggests that the cells are not fully 
activated merely by the culture conditions and that they 
can be pushed towards a more activated state with the 
addition of classical inducers. The biliary epithelial cell 
marker cytokeratin 19 was not detected in these sphe-
roids (Supplemetary Fig. 1a).
NPCs protect against APAP‑induced toxicity
To assess how the addition of NPCs would impact upon 
drug-induced toxicity, spheroids were treated with the model 
hepatotoxicant acetaminophen (APAP) and the response was 
assessed via a panel of readouts. NPCs protected against 
APAP-induced toxicity, with higher concentrations required 
to cause a depletion in cellular ATP (Fig. 2a, b). A slight 
difference in sensitivity was seen already after 24/72 h treat-
ment (Fig. 2b), and after repeated treatments of up to 14 days 
this difference increased to approximately threefold. At the 
same time, cellular glutathione was depleted to a greater 
extent in hepatocyte only spheroids, which might suggest 
they are more sensitive to APAP-induced oxidative stress 
(Fig. 2c). Glutathione depletion was an early event, occur-
ring after 6 h APAP exposure (Supplementary Fig. 1b).
The hepatotoxicity of APAP is thought to be related to 
the formation of the reactive metabolite, NAPQI, which is 
highly protein-reactive (McGill et al. 2013). We therefore 
assessed the formation of APAP metabolites in each cell 
model via LC–MS/MS. Although similar amounts of both 
the glucuronide and sulfate metabolite were measured in 
mono- and co-culture (Fig. 2d), less of the APAP-GSH 
conjugate (which may serve as a surrogate for NAPQI pro-
duction) could be detected in media from NPC-containing 
spheroids. Both hepatocyte only and NPC-supplemented 
spheroids contained the same number of hepatocytes (1500 
cells/spheroid). To understand whether this difference was 
related to differential expression of the enzymes involved 
in APAP metabolism, mRNA levels of CYP1A2, 2E1 and 
3A4 were investigated (Fig. 3). Expression of each of these 
enzymes was lower in NPC-containing spheroids, despite 
equivalent albumin expression (CYP1A2 = −  4.4-fold; 
CYP2E1 = − 3.3-fold; CYP3A4 = − 3.8-fold; ALB = − 1.4-
fold). In addition, APAP treatment resulted in a downregu-
lation of each of these enzymes. This effect was more pro-
nounced in PHH spheroids, particularly when considering 
that higher levels of each of CYPs were present initially. 
Expression of the Nrf-2 target genes Nqo1 and Srxn1 was 
also investigated and both were upregulated by APAP 
treatment, suggesting that oxidative stress was induced in 
both models. Basal expression of Nqo1 was higher in the 
NPC-containing spheroids and not as inducible as Srxn1. 
Co-incubation with the non-selective CYP inhibitor 1-amin-
obenzotriazole (1 mM) resulted in a modest protective effect 
(Supplemetary Fig. 1c).
Table 3  Summary of antibodies and conditions used for immunohis-
tochemistry on the Ventana Ultra
Antibody Supplier Host Pretreatment Dilution
CD68 Novocastra Mouse mCC1, pH8 1:100
α-SMA Dako Mouse mCC1, pH8 1:100
COL1A1 Biosite Rabbit stdCC1, pH8 1:1000
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Differential expression and release of hepatic 
miRNAs in hepatocyte only and NPC‑containing 
spheroids
miRNAs can serve as sensitive and specific biomarkers 
of drug-induced toxicity. Here, we investigated a panel of 
miRNAs, five of which have been associated with liver 
injury following APAP poisoning (miR-122, miR-151, 
miR-382, miR-483 and miR-885) (Vliegenthart et al. 2015) 
and one associated with inflammation (miR-155) (Bala 
et al. 2012). Plasma elevations in liver-enriched miRNAs 
are likely to reflect damage to hepatocytes and a leakage of 
Fig. 1  Characterisation of primary human hepatocyte spheroids supple-
mented with non-parenchymal cells. a The number of supplementary 
non-parenchymal cells was titrated and viability was assessed at differ-
ent timepoints by measuring cellular ATP content. Data represent the 
average of six spheroids ± SD. The black line indicates hepatocyte only 
spheroids. All spheroids contained 1500 hepatocytes. b LPS-induced 
secretion of IL-6 was measured periodically to determine Kupffer cell 
function. Media from six spheroids was pooled after 48  h stimula-
tion with 10 µg/ml LPS. In the absence of LPS, < 15 pg/ml IL-6 was 
detected from all conditions. c Histological assessment of 3D sphe-
roids via H + E staining and immunohistochemistry for markers of 
Kupffer cells (CD68) indicates the presence NPCs. Scale bar repre-
sents 100 µm. d Increased expression of activated stellate cell markers 
α-SMA and COL1A1 following activation of hepatic stellate cells with 
TGF-β (10 ng/ml). Spheroids were pooled after 48 h and either lysed 
with Qiazol for RNA isolation or fixed with formalin for IHC
 Archives of Toxicology
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cellular contents. Of the six miRNAs investigated, only miR-
122 was reliably detected in media samples from APAP-
treated spheroids (Fig. 4a). In support of the increased sensi-
tivity observed in PHH only spheroids, the level of miR-122 
release following APAP treatment was higher in PHH only 
spheroids compared to those containing additional NPCs, 
although miR-122 release was only induced at the highest 
APAP concentrations (Fig. 4a). Cellular levels of miR-122, 
however, were not affected, likely due to the very high lev-
els present (Fig. 4b). Expression was equivalent in the two 
models.
Elevations in plasma miR-151 and miR-885 follow-
ing APAP poisoning have also been reported previously 
(Vliegenthart et al. 2015). In our model, neither of these 
miRNAs were detected in media from a single spheroid, 
likely due to the limits of detection of the assay and much 
Fig. 2  Hepatic non-parenchymal cells protect against acetaminophen 
toxicity. a Cytotoxicity of APAP was determined by measuring cel-
lular ATP at various timepoints. PHH only spheroids (left panel) were 
more sensitive to APAP toxicity than spheroids containing NPCs 
(right panel), particularly after repeated treatments. b Concentrations 
resulting in a 50% reduction in viability  (EC50) were calculated for 
both models—lower concentrations of APAP were required to cause 
a loss of viability in PHH only spheroids. c Glutathione depletion was 
also observed at lower concentrations of APAP when PHH were cul-
tured in the absence of NPCs. This occurred prior to ATP depletion. 
Data represent the average ± SD of six spheroids. d APAP metabo-
lites were measured in the media after 72 h treatment. Data represent 
the average ± SD of two biological replicates consisting of pooled 
media from three spheroids each
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lower cellular expression compared to miR-122. For miR-
151, APAP had no effect on cellular expression, and both 
models expressed this miRNA at equivalent levels (Fig. 4b). 
A slight reduction in miR-885 expression was observed fol-
lowing treatment of PHH only spheroids with APAP, how-
ever, this varied substantially between biological replicates 
(Fig. 4b).
Levels of miR-483 are reported to decrease in the plasma 
following APAP overdose (Vliegenthart et al. 2015). Here, 
APAP treatment appeared to cause a reduction in cellular 
expression of miR-483 in both models, this was of a greater 
magnitude in PHH only spheroids. This was not determined 
to be statistically significant however.
Both miR-155 and miR-382 were expressed at increased 
levels in spheroids containing NPCs (Fig. 4b). For miR-
155, NPC-containing spheroids expressed approximately 
sixfold higher levels than PHH only spheroids at baseline. 
Treatment with the highest concentration of APAP (10 mM) 
resulted in a further reduction in miR-155 in PHH only 
spheroids. No such APAP effect was seen in spheroids con-
taining NPCs. This may represent either a loss of miR-155 
from damaged cells, or a downregulation in its expression. 
miR-382 was almost exclusively expressed in spheroids 
supplemented with NPCs. Under control conditions this 
equated to a > 7500-fold increase in expression compared 
to PHH only. No effect of APAP treatment was observed in 
either model.
NPCs from multiple donors confer protection 
against APAP toxicity
Donor-differences are important to consider when using 
human cells in vitro. We therefore obtained cryopreserved 
NPCs from three additional donors to see whether the protec-
tion against acetaminophen toxicity could be replicated. The 
same hepatocyte donor was used to remove any potential influ-
ence of differences in e.g. drug metabolizing enzyme expres-
sion. For all donors some degree of protection was conferred in 
the presence of supplementary NPCs (Fig. 5a; green shading) 
although the magnitude of this effect varied among donors 
and across timepoints. We attempted to explore the reasons 
behind these variations by comparing the expression of CD68 
(Fig. 5b, c), miR-382, and miR-155 (Fig. 5c) between batches 
to understand whether it was possible to correlate the num-
ber and type of NPCs present to the protective effect seen. 
In all co-cultured spheroids increased levels of these markers 
Fig. 3  Acetaminophen induces changes in cytochrome P450 enzyme 
expression and markers of oxidative stress. CYP1A2, CYP2E1, 
and CYP3A4 have been implicated in the metabolism of APAP 
to the reactive metabolite NAPQI. Baseline expression of these 
enzymes was higher in PHH only spheroids (black bars) compared to 
PHH + NPC spheroids (grey bars). Albumin expression was assessed 
as a marker for hepatocytes. Data represent the average of three rep-
licates, generated from RNA isolated from 24 pooled spheroids. 
GAPDH was used as a housekeeping gene and all data are relative to 
the untreated PHH only spheroids. Srxn1 and Nqo1 were investigated 
as markers of oxidative stress
 Archives of Toxicology
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were detected compared to hepatocyte only spheroids in the 
same experiment, however, there was no clear trend in terms 
of the level of marker expression and the response to APAP. 
Despite this, it may still be important to understand the rela-
tive numbers of eg. Kupffer cells, stellate cells, and LSECs for 
Fig. 4  Changes in miRNA expression and release following APAP 
treatment are influenced by the presence of hepatic non-parenchy-
mal cells. a Acetaminophen treatment results in release of miR-122 
to the media, particularly in PHH only spheroids (black bars). Data 
represent the average of three biological replicates consisting media 
pooled from six spheroids each, following 72 h treatment. Of the six 
miRNAs investigated, only miR-122 was reliably detected in media 
samples. Ct values were interpolated from a standard curve generated 
from synthetic miR-122. b Cellular expression of miR-122, miR-151, 
miR-155, miR-382, miR-483 and miR-885 was assessed following 
72 h APAP treatment. Six spheroids were pooled and lysed with Qia-
zol prior to qPCR with TaqMan Advanced reagents. Data represent 
the average of three biological replicates. U6 expression was used 
to normalise for RNA input. Expression was compared to untreated 
PHH spheroids and  statistical significance was determined by Two-
way ANOVA with corrections for multiple testing
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future studies incorporating NPCs—particularly when mixed 
preparations are used.
Discussion
In vitro models incorporating human cells and/or tissue 
offer the possibility to investigate clinically important tox-
icity mechanisms at an early stage in drug development. 
The choice of culture system can, however, significantly 
impact cellular functionality and the expression of key 
phenotypic markers (Baker et al. 2018; Lauschke et al. 
2016a, b; Lin and Khetani 2016). Culturing primary 
human hepatocytes as three-dimensional spheroids pre-
serves many of the features which are rapidly lost in con-
ventional 2D monolayers (Bell et  al. 2016). However, 
despite this improved phenotype, most of the studies 
describing the use of spheroids for investigating DILI have 
Fig. 5  Non-parenchymal cells from multiple donors protect against 
APAP toxicity. a APAP cytotoxicity was compared through the cal-
culation of  EC50 values after 72 h, 7-day or 14-day treatment. NPC 
donors 3 and 4 were investigated in the same experiment and there-
fore are compared to the same PHH only spheroids. Green shading 
indicates a protective effect of NPCs. Yellow shading indicates equiv-
alent toxicity in the two models. b The presence and distribution of 
Kupffer cells was assessed by IHC for the macrophage marker CD68. 
Some CD68 staining was observed in PHH only spheroids. This was 
increased with the introduction of supplementary NPCs. c The dif-
ference in mRNA expression of CD68 was quantitated by calculat-
ing the fold increase between NPC-containing cultures and PHH only 
spheroids in the same experiment with GAPDH used as a housekeep-
ing gene. miR-382 and miR-155 were also present at higher levels in 
NPC-containing spheroids generated from all NPC donors
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predominantly focused on cytotoxicity endpoints rather 
than exploring how they can best be exploited to under-
stand the underlying mechanisms.
Incorporating non-parenchymal cells into in vitro models 
may improve in vivo relevance, particularly where inflamma-
tion or innate immune responses are thought to be important 
(Godoy et al. 2013). In our present study, we demonstrated 
that introducing NPCs to PHH spheroids at the time of seed-
ing did not have a detrimental effect on cellular viability and 
that the function of Kupffer cells and stellate cells could be 
retained. Titrating the ratio of PHH:NPC led us to selecting 
a ratio of 2:1 (1500 PHH and 750 NPC) based on the loss 
of response to LPS challenge when NPCs were included at 
lower numbers. This ratio has also been selected in other 
studies (Bell et al. 2016), although the actual physiological 
relevance of this ratio remains to be determined. Estimates 
of the number of different cell types present in the liver have 
suggested it is comprised of 60–65% hepatocytes, 15–20% 
endothelial cells, 10–15% Kupffer cells and 5–10% stellate 
cells (Dash et al. 2009; Bale et al. 2016), which is close to 
the ratio we have selected. In addition, actual ratios in vivo 
are likely to fluctuate depending on the current inflamma-
tory status of the tissue. Another study focusing on screen-
ing DILI compounds for hepatotoxicity utilised spheroids 
containing 90% PHH and 10% NPC (Foster et al. 2019). In 
this study, the functionality of the NPCs was not assessed. 
The rationale for adding NPCs to PHHs may vary depending 
on the endpoints/mechanisms which are under investigation 
and in some instances, NPCs are merely added to improve 
spheroid formation. We selected mixed preparations of cryo-
preserved NPCs, assuming that the ratio of different NPC 
subtypes would be maintained in a similar proportion to the 
in vivo situation. However, the isolation processes selected 
may cause a bias towards certain cell types. Indeed, it is dif-
ficult to know whether any differences in NPC batches rep-
resent genuine differences in cellular composition between 
donors or rather occur as a result of the isolation process. 
Other models have included isolated preparations of Kupffer 
cells (Rose et al. 2016; Sunman et al. 2004) or stellate cells 
(Thomas et  al. 2006), sometimes in combination with 
hepatic cell lines rather than primary hepatocytes. It is how-
ever unclear how stable a model including several different 
primary cell types from multiple different donors would be. 
For continued investigations into the role of non-parenchy-
mal cells in hepatotoxicity we suggest that characterisation 
of cell types should be performed in all experiments. Ideally 
this should include phenotyping of the cultures using immu-
nohistochemistry, to give a complete overview of the distri-
bution of each cell type. For practical purposes, performing 
qPCR for a small panel of markers is likely to provide a 
reasonable measure of the variability of NPC composition 
between donors and experiments. Furthermore, although the 
same hepatocyte donor was used throughout the study, we 
found that the PHH fraction included contaminating NPCs, 
which in some preparations clearly impacted on the phe-
notype of the spheroids (Figs. 1, 5). This may contribute 
to the variability seen in some of the  EC50 values between 
different experiments. The reproducibility of the model may 
be improved through using hepatic cell lines such as HepG2 
or HepaRG (hepatocytes), LX-1 (stellate cells) or THP-1 
(macrophages) (Prestigiacomo et al. 2017), at the expense 
of key cellular functionality only provided by primary cells.
One limitation of the spheroid model is that cells are 
mixed together in suspension and therefore it is not pos-
sible to control the exact localisation of each individual cell 
type. The proximity of each of the cell types and interaction 
between them may be important for some of their function-
ality eg. LSECs lining the sinusoids. For situations where a 
retained tissue architecture is vital, microphysiological sys-
tems (Foster et al. 2019) or bioprinting techniques (Ma et al. 
2016; Nguyen et al. 2016) may provide ways to incorporate 
key anatomical features, such as the space of Disse. How-
ever, these systems in general have much lower throughput 
than 3D spheroids, which can be produced in 96- or 384-well 
plates. Using this relatively simple model, we have shown 
it is possible to maintain functional NPCs for a prolonged 
period as well as replicate toxicological effects that have 
been reported in vivo.
Acetaminophen toxicity has been widely studied as a 
model of drug-induced liver injury and is frequently used as 
an example of how metabolic activation and protein adduct 
formation can contribute to cell death. Non-parenchymal 
cells may be important in the toxicological response to 
APAP, and in particular the role of Kupffer cells has been 
widely discussed. Some groups have claimed that Kupffer 
cells exacerbate hepatic damage likely through the release 
of inflammatory mediators such as TNF-α (Ito et al. 2003; 
Laskin et al. 1995; Michael et al. 1999). This activation may 
occur directly or secondary to hepatocyte necrosis. How-
ever, these studies all used gadolinium chloride to inhibit the 
phagocytic activity of Kupffer cells, a compound which has 
been questioned due to its effects on reactive oxygen species 
formation (Jaeschke et al. 2012).
In another study, in which depletion of Kupffer cells was 
achieved with administration of liposomes loaded with clo-
dronate, mice experienced more severe hepatotoxicity fol-
lowing APAP treatment, as indicated by histological changes 
and elevations in plasma ALT (Ju et al. 2002). The authors 
suggested that this was due to a reduction in the secretion 
of regulatory mediators such as IL-10. It is therefore likely 
that the balance between pro- and anti-inflammatory signals 
contributes to the severity of the liver damage caused. Addi-
tionally, activation of Kupffer cells may serve as an impor-
tant signal in hepatocyte repair and regeneration (Jaeschke 
et al. 2012). Here, we have seen that mixed preparations of 
NPCs from multiple donors protect against APAP-induced 
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hepatotoxicity. Although Kupffer cells are present in these 
preparations (as confirmed by CD68 staining), it cannot be 
ruled out that the other cell types may also contribute to the 
protective effect and there is some evidence that depletion 
of activated stellate cells with gliotoxin can result in more 
severe APAP liver injury (Shen et al. 2011).
Bioactivation to a protein-reactive imine, N-acetyl-p-ben-
zoquinone (NAPQI), is a key step in the hepatic toxicity of 
APAP. NAPQI formation is associated with covalent binding 
to proteins, glutathione depletion and generation of reactive 
oxygen species which ultimately results in cellular necro-
sis. Microsomal incubations in both rat and human have 
attributed the formation of NAPQI to the cytochrome P450 
enzymes: CYP2E1, CYP3A4, and CYP1A2 (Patten et al. 
1993), although CYP2E1 appears to be the major enzyme 
involved in vivoin humans (Manyike et al. 2000). We quan-
tified the amount of APAP-GSH formed in each of the cell 
models as a surrogate for NAPQI formation and found that 
levels of APAP-GSH were lower in spheroids which con-
tained NPCs, suggesting either that less bioactivation occurs 
in this model or that APAP-GSH is more rapidly degraded in 
the presence of NPCs. At the same time mRNA expression 
of CYP1A2 (fourfold), CYP2E1 (threefold) and CYP3A4 
(fourfold) was lower in NPC-containing spheroids, despite 
equivalent expression of the hepatocyte marker albumin. 
CYP expression was decreased further upon APAP treat-
ment, likely either as a negative feedback mechanism or due 
to the cytotoxic effect of APAP. The reasons for the reduced 
expression of CYP enzymes in NPC-containing spheroids 
are however unclear. It is well established that cytokines 
can be involved in the downregulation of CYP450 enzymes 
(Klein et al. 2014) however, no IL-6 secretion was detected 
in the absence of LPS in either model.
MicroRNAs provide post-transcriptional regulation of 
gene expression through complimentary binding to the 
3′-UTR of mRNA, resulting in either degradation of the 
transcript or repression of translation. The tissue specific-
ity of some miRNAs has led to significant interest in their 
use as biomarkers of tissue injury, as circulating levels of 
a specific miRNA suggest leakage from damaged cells. 
Expression of miR-122 is almost entirely confined to the 
liver, where it makes up more than 70% of the total miRNA 
present (Lagos-Quintana et al. 2002) and in recent years it 
has emerged as a sensitive and specific marker of hepatic 
damage which can be monitored in the clinic, in animal 
studies and in vitro (Kia et al. 2015a, b; Lewis et al. 2011; 
Wang et al. 2009). Due to the small number of cells pre-
sent in each spheroid it is perhaps unsurprising that the only 
miRNA reliably detected in cell culture media samples was 
miR-122. Previous in vitro studies in both 2D and 3D have 
indicated that miR-122 is at least as sensitive as ATP and 
LDH in reporting cytotoxicity (Foster et al. 2019; Kia et al. 
2015a, b; Proctor et al. 2017), however currently it does 
not provide any additional mechanistic information. Where 
miR-122 may come into further importance is for example in 
the use of multi-organ in vitro systems where tissue-specific 
markers will be of significant value (Skardal et al. 2017).
When a random forest statistical model was applied to the 
miRNA profiling data obtained from the plasma of APAP 
poisoning patients, decreases in the plasma level of miR-382 
best predicted patients that would experience severe liver 
injury (Vliegenthart et al. 2015). This is in direct contrast 
to miR-122, which was increased in the plasma, suggesting 
either that miR-382 is produced less or that it is degraded 
more quickly in patients with the most severe APAP liver 
injury. It could also be taken up into tissues. The presence 
of significantly higher levels of miR-382 in co-culture 
spheroids compared to PHH only spheroids is therefore an 
interesting finding and may point towards a potential role 
for miR-382 in the protective effect of NPCs. Increased 
expression of miR-382 in mouse liver has previously been 
observed following partial hepatectomy (Bei et al. 2015), 
with the authors highlighting that overexpression of miR-
382 in hepatic cell lines resulted in increased proliferation, 
suggesting a possible role in liver regeneration. Limited 
studies currently exist which have looked at miR-382 in the 
liver, and even fewer that utilize primary human cells. CYP 
enzymes are not predicted targets of miR-382 (miRTarBase).
The study from Vliegenthart et al. (2015) did not iden-
tify miR-155 as being significantly dysregulated in APAP 
poisoning, however it was included in the current study due 
to its role in inflammation and immune cell development 
(Connell et al. 2012; O’Connell et al. 2007). It has also fea-
tured in a number of other studies looking at APAP toxicity, 
with miR-155−/− mice experiencing more severe liver dam-
age following APAP treatment (Yuan et al. 2016), likely 
due to an increase in expression of the pro-inflammatory 
cytokines TNF-a and IL-6. In general, the observation that 
NPCs contain different miRNAs to hepatocytes may be use-
ful for understanding the mechanisms underlying drug toxic-
ity or for identifying compounds that are toxic to a specific 
cell type. Unravelling the signalling pathways regulated by a 
specific miRNA will be challenging due to the fact that each 
miRNA has many mRNA targets.
To summarise, we have successfully introduced func-
tional non-parenchymal cells into three-dimensional sphe-
roids containing primary human hepatocytes and utilised 
this model to investigate APAP toxicity. The possibility to 
induce both inflammation and steatosis in NPC-containing 
spheroids highlights the potential value of co-cultures in 
investigating complex liver pathologies as well as confirm-
ing that expected signalling pathways are activated in the 
presence of model inducers. The protective effect of NPCs 
on APAP toxicity was observed via multiple endpoints and 
as such suggests that the interaction between multiple cell 
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types can have important consequences for the response to 
hepatotoxins.
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